Chai Discovery
AI drug-discovery company building multimodal foundation models and computer-aided design tools for molecular structure prediction and de novo therapeutic design.
$3.8B*192%increase
| Name | Type | Category | Launched | Latest release | Status |
|---|---|---|---|---|---|
| Chai Molecular Design Platform | Platform | Drug Discovery | Sep 2024 | — | active |
* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology